Your browser doesn't support javascript.
loading
Paraptosis Inducer to Effectively Trigger Immunogenic Cell Death for Metastatic Tumor Immunotherapy with IDO Inhibition.
Zheng, Rong-Rong; Zhao, Lin-Ping; Huang, Chu-Yu; Cheng, Hong; Yang, Ni; Chen, Zu-Xiao; Cai, Hua; Zhang, Wei; Kong, Ren-Jiang; Li, Shi-Ying.
Afiliación
  • Zheng RR; Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, People's Republic of China.
  • Zhao LP; Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, People's Republic of China.
  • Huang CY; Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, People's Republic of China.
  • Cheng H; Biomaterials Research Center, School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, People's Republic of China.
  • Yang N; Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, People's Republic of China.
  • Chen ZX; Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, People's Republic of China.
  • Cai H; Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, People's Republic of China.
  • Zhang W; Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, People's Republic of China.
  • Kong RJ; Biomaterials Research Center, School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, People's Republic of China.
  • Li SY; Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, People's Republic of China.
ACS Nano ; 17(11): 9972-9986, 2023 06 13.
Article en En | MEDLINE | ID: mdl-37200049
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Muerte Celular Inmunogénica / Neoplasias Límite: Humans Idioma: En Revista: ACS Nano Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Muerte Celular Inmunogénica / Neoplasias Límite: Humans Idioma: En Revista: ACS Nano Año: 2023 Tipo del documento: Article